Roche: European Commission Approves Xofluza For Children Aged One Year And Above
12/1 07:18
(RTTNews) - Roche (RHHBY) announced the European Commission has approved Xofluza in children aged one year and above for the treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. The approval is based on the results of the phase III miniSTONE-2 and...